MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Clinical trial NCT00911066 · COMPLETED
Trial details
- NCT number
- NCT00911066
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2013-08-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.